Score Overview
Explore the 2021 public Archive ranking →
Where Fresenius Medical Care Corporation has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 30 years of fundamentals. FMS does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 22.95 | — |
1 Year2025-09-26 | $ 24.59 | -6.66% |
5 Years2021-09-28 | $ 30.62 | -25.04% |
10 Years2016-09-28 | $ 35.27 | -34.94% |
20 Years2006-09-28 | $ 15.17 | 51.26% |
30 Years1996-09-27 | $ 7.13 | 222.01% |
All Time1996-09-19 | $ 6.82 | 236.48% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1996-09-19 |
|---|---|---|---|---|---|---|---|
| Price | $ 22.95 | $ 24.59 | $ 30.62 | $ 35.27 | $ 15.17 | $ 7.13 | $ 6.82 |
| Return | — | -6.66% | -25.04% | -34.94% | 51.26% | 222.01% | 236.48% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | € 19.50B | € 941M | |
| 2025 | € 19.62B | € 978M | € 1.59B |
| 2024 | € 19.33B | € 537M | € 1.34B |
| 2023 | € 19.45B | € 498M | € 1.55B |
| 2022 | € 19.39B | € 673M | € 1.46B |
| 2021 | € 17.61B | € 969M | € 1.64B |
| 2020 | € 17.85B | € 1.16B | € 1.24B |
| 2019 | € 17.47B | € 1.19B | € 1.16B |
| 2018 | € 16.54B | € 1.98B | € 2.26B |
| 2017 | € 17.78B | € 1.28B | € 993M |
| 2016 | € 17.03B | € 1.18B | € 974M |
| 2015 | € 15.30B | € 941M | € 751M |
| 2014 | € 13.01B | € 859M | € 678M |
| 2013 | € 10.58B | € 803M | € 530M |
| 2012 | € 10.43B | € 897M | € 520M |
| 2011 | € 9.87B | € 826M | € 352M |
| 2010 | € 9.06B | € 735M | € 393M |
| 2009 | € 7.85B | € 621M | € 210M |
| 2008 | € 7.62B | € 587M | € 159M |
| 2007 | € 6.66B | € 491M | € 167M |
| 2006 | € 6.43B | € 406M | € 120M |
| 2005 | € 5.71B | € 384M | € 71M |
| 2004 | € 4.59B | € 296M | € 43M |
| 2003 | € 4.38B | € 262M | € 38M |
| 2002 | € 4.84B | € 276M | € 61M |
| 2001 | € 5.46B | € 71M | € 69M |
| 2000 | € 4.47B | € 225M | € 68M |
| 1999 | € 3.81B | -€ 247M | € 34M |
| 1998 | € 2.98B | € 16M | € 27M |
| 1997 | € 2.96B | € 81M |
Fresenius Medical Care Corporation fundamental performance
Between 2020 and 2025, revenue grew from € 17.85B to € 19.62B and net income declined from € 1.16B to € 978M. Revenue increased in 3 of those 5 years; net income in 2.
Across Fresenius Medical Care Corporation's full reported history, from 1997 to 2025, revenue grew from € 2.96B to € 19.62B and net income grew from € 81M to € 978M. Revenue increased in 79% of the years measured; net income in 62%.
Fresenius Medical Care Corporation currently holds a 20-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.
Membership
Explore FMS with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
